Search Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective Source: Changing the Course of Patient Outcomes in Non-Small-Cell Lung Cancer: Novel Therapeutic Approaches for Early-Stage Disease DOWNLOAD SLIDESET Download this slideset to review key data on the use of neoadjuvant immune checkpoint inhibitor–based therapy in resectable early-stage NSCLC from a surgeon’s perspective. Format: Microsoft PowerPoint (.ppt) File Size: 2.85 MB Released: December 1, 2021 Acknowledgements Provided by Clinical Care Options, LLC Contact Info Supported by an educational grant from Genentech, a member of the Roche Group Program Contents IO for Early-Stage NSCLC Microlearning Med Onc Perspective: Module Med Onc Perspective: Slides Pharmacist Perspective: Module Pharmacist Perspective: Slides Surgeon Perspective: Module Surgeon Perspective: Slides Slidesets Resource On Demand Webcast (Coming Soon) Related Content ClinicalThought ClinicalThought Current Status of EGFR Tyrosine Kinase Inhibitor Combination Therapy in the Treatment of Newly Diagnosed EGFR-Mutated Advanced NSCLC VIEW CLINICALTHOUGHT VIEW MORE Slideset Slideset ExpressPoints EGFR Exon 20–Altered NSCLC: A Personalized Approach to Improve Patient Outcomes VIEW SLIDESET VIEW MORE PDF PDF Podcast Pearls Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer VIEW PDF VIEW MORE Text Module Text Module Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective CME CE VIEW TEXT MODULE VIEW MORE User Resources My Profile Contact Us Help Site Requirements Privacy Policy Terms of Use Educational Formats Topics Programs Conference Coverage ClinicalThought Podcast Slides Tools Live Events Specialty Sites Cardiology Endocrinology Health Disparities Hepatitis HIV Immunology Infectious Disease Internal Medicine Neurology/Psychiatry Oncology Pulmonology Other CCO Sites CCO inPractice About CCO Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials. © 2021 Clinical Care Options, LLC. All rights reserved. Cookie Preferences